Swords, R., Coutre, S., Maris, M., Zeidner, J., Foran, J., Cruz, J., … Savona, M. (2018). Pevonedistat, a first-in-class NEDD8-activating enzyme (NAE) inhibitor, combined with azacitidine, in patients with AML. Blood. https://doi.org/10.1182/blood-2017-09-805895 (Original work published 2018)